tiprankstipranks
Trending News
More News >
JBM (Healthcare) Ltd. (HK:2161)
:2161
Hong Kong Market
Advertisement

JBM (Healthcare) Ltd. (2161) Ratios

Compare
1 Followers

JBM (Healthcare) Ltd. Ratios

HK:2161's free cash flow for Q2 2024 was HK$0.52. For the 2024 fiscal year, HK:2161's free cash flow was decreased by HK$ and operating cash flow was HK$0.29. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
1.65 1.70 2.06 2.07 2.70
Quick Ratio
1.27 1.42 1.69 1.72 2.07
Cash Ratio
0.64 0.78 0.54 0.69 0.73
Solvency Ratio
0.59 0.27 0.20 0.15 0.12
Operating Cash Flow Ratio
1.07 0.75 0.47 0.43 0.38
Short-Term Operating Cash Flow Coverage
3.73 1.60 1.00 0.98 3.54
Net Current Asset Value
HK$ 60.65MHK$ -41.01MHK$ -98.56MHK$ -149.94MHK$ -383.41M
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.13 0.16 0.19 0.34
Debt-to-Equity Ratio
0.09 0.18 0.23 0.30 0.71
Debt-to-Capital Ratio
0.08 0.15 0.19 0.23 0.42
Long-Term Debt-to-Capital Ratio
0.00 0.06 0.11 0.16 0.40
Financial Leverage Ratio
1.39 1.42 1.43 1.53 2.08
Debt Service Coverage Ratio
2.84 0.98 1.16 1.53 6.69
Interest Coverage Ratio
48.16 8.26 5.68 9.57 61.36
Debt to Market Cap
0.03 0.16 0.22 0.20 0.23
Interest Debt Per Share
0.11 0.21 0.25 0.31 0.52
Net Debt to EBITDA
-0.28 0.25 1.70 1.52 4.49
Profitability Margins
Gross Profit Margin
51.75%36.12%35.04%45.56%49.84%
EBIT Margin
28.09%16.36%9.15%12.36%14.37%
EBITDA Margin
33.53%21.41%20.72%28.83%22.99%
Operating Profit Margin
29.14%13.02%8.95%17.85%13.59%
Pretax Profit Margin
28.11%15.15%8.01%10.79%14.14%
Net Profit Margin
22.74%10.97%6.06%5.69%10.75%
Continuous Operations Profit Margin
23.86%12.17%5.74%7.71%10.83%
Net Income Per EBT
80.91%72.42%75.67%52.72%76.01%
EBT Per EBIT
96.46%116.32%89.48%60.45%104.09%
Return on Assets (ROA)
11.63%4.07%1.85%1.64%3.00%
Return on Equity (ROE)
16.53%5.79%2.65%2.50%6.24%
Return on Capital Employed (ROCE)
18.01%5.61%3.02%5.70%4.09%
Return on Invested Capital (ROIC)
14.29%4.28%2.19%4.00%3.30%
Return on Tangible Assets
28.32%21.39%10.53%8.40%8.04%
Earnings Yield
6.31%5.93%3.03%1.89%2.13%
Efficiency Ratios
Receivables Turnover
6.23 4.70 3.17 2.97 5.29
Payables Turnover
20.41 11.08 11.83 16.62 25.73
Inventory Turnover
3.68 6.09 5.51 4.50 3.00
Fixed Asset Turnover
5.01 3.15 2.24 2.06 2.10
Asset Turnover
0.51 0.37 0.30 0.29 0.28
Working Capital Turnover Ratio
4.72 3.82 2.87 2.50 -1.53
Cash Conversion Cycle
140.01 104.61 150.55 182.07 176.45
Days of Sales Outstanding
58.58 77.62 115.16 122.98 68.99
Days of Inventory Outstanding
99.31 59.91 66.23 81.06 121.65
Days of Payables Outstanding
17.88 32.93 30.84 21.97 14.19
Operating Cycle
157.89 137.54 181.39 204.03 190.64
Cash Flow Ratios
Operating Cash Flow Per Share
0.32 0.16 0.07 0.07 0.04
Free Cash Flow Per Share
0.31 0.15 0.06 0.04 0.04
CapEx Per Share
<0.01 <0.01 <0.01 0.03 <0.01
Free Cash Flow to Operating Cash Flow
0.97 0.94 0.88 0.61 0.88
Dividend Paid and CapEx Coverage Ratio
3.71 11.58 8.50 2.57 8.46
Capital Expenditure Coverage Ratio
37.19 17.94 8.50 2.57 8.46
Operating Cash Flow Coverage Ratio
2.95 0.81 0.28 0.22 0.08
Operating Cash Flow to Sales Ratio
0.36 0.28 0.15 0.15 0.10
Free Cash Flow Yield
9.92%14.31%6.51%3.00%1.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.84 16.86 33.03 52.99 47.06
Price-to-Sales (P/S) Ratio
3.56 1.85 2.00 3.02 5.06
Price-to-Book (P/B) Ratio
2.57 0.98 0.88 1.32 2.94
Price-to-Free Cash Flow (P/FCF) Ratio
10.08 6.99 15.36 33.29 57.18
Price-to-Operating Cash Flow Ratio
9.93 6.60 13.55 20.32 50.42
Price-to-Earnings Growth (PEG) Ratio
0.48 0.13 3.63 -1.18 -2.16
Price-to-Fair Value
2.57 0.98 0.88 1.32 2.94
Enterprise Value Multiple
10.34 8.89 11.37 11.97 26.50
Enterprise Value
2.50B 990.46M 956.51M 1.37B 2.32B
EV to EBITDA
10.34 8.89 11.37 11.97 26.50
EV to Sales
3.47 1.90 2.36 3.45 6.09
EV to Free Cash Flow
9.82 7.19 18.06 38.11 68.83
EV to Operating Cash Flow
9.55 6.79 15.94 23.27 60.70
Tangible Book Value Per Share
0.29 -0.12 -0.14 -0.19 -0.16
Shareholders’ Equity Per Share
1.23 1.11 1.04 1.01 0.74
Tax and Other Ratios
Effective Tax Rate
0.15 0.17 0.23 0.26 0.18
Revenue Per Share
0.87 0.58 0.45 0.44 0.43
Net Income Per Share
0.20 0.06 0.03 0.03 0.05
Tax Burden
0.81 0.72 0.76 0.53 0.76
Interest Burden
1.00 0.93 0.88 0.87 0.98
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.07 0.10 0.10 0.11 0.11
Stock-Based Compensation to Revenue
0.01 <0.01 0.00 0.00 0.00
Income Quality
1.60 2.56 2.44 2.61 0.71
Currency in HKD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis